Transcriptional activation of the promoter of human cytomegalovirus immediate early gene (CMV-IE) by the hepatitis B viral X protein (HBx) through the NF-kappaB site
Assogba, B.Dossou.; Choi, B.Hyune.; Rho, H.Mo.
Virus Research 84(1-2): 171-179
2002
ISSN/ISBN: 0168-1702
PMID: 11900849
Accession: 011582322
The reactivation of latent cytomegalovirus (CMV) in a human by another viral infection may induce virus-related symptoms. Based on this presumption, we investigated the effect of HBx on the activation of the CMV-IE, which is also known as a transactivator and potential oncogene. The HBx transactivated the CMV-IE promoter by up to 4- and 18-fold factors in human liver HepG2 and lung fibroblast MRC-5 cells, respectively.
PDF emailed within 1 workday: $29.90
Related References
Assogba, B.D.; Choi, B.H.; Rho, H.M. 2002: Transcriptional activation of the promoter of human cytomegalovirus immediate early gene by the hepatitis B viral X protein through the NF-kappaB site Virus Research 84(1-2): 171-179, 20 MarchKwon, J.Ah.; Rho, H.Mo. 2002: Hepatitis B viral core protein activates the hepatitis B viral enhancer II/pregenomic promoter through the nuclear factor kappaB binding site Biochemistry and Cell Biology 80(4): 445-455
Schwartz, R.; Sommer, M.H.; Spector, D.H. 1994: Site-specific binding of the human cytomegalovirus IE2 86 kDa protein to an early gene promoter Journal of Cellular Biochemistry Suppl 1994(18C): 53
Scully, A.L.; Sommer, M.H.; Schwartz, R.; Spector, D.H. 1995: The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations Journal of Virology 69(10): 6533-6540
Schwartz, R.; Sommer, M.H.; Scully, A.; Spector, D.H. 1994: Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter Journal of Virology 68(9): 5613-5622
DeMeritt, I.B.; Milford, L.E.; Yurochko, A.D. 2004: Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter Journal of Virology 78(9): 4498-4507
Benoit, V.; Hellin, A.C.; Huygen, S.; Gielen, J.; Bours, V.; Merville, M.P. 2000: Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter Oncogene 19(41): 4787-4794
Gealy, C.; Humphreys, C.; Dickinson, V.; Stinski, M.; Caswell, R. 2007: An activation-defective mutant of the human cytomegalovirus IE2p86 protein inhibits NF-kappaB-mediated stimulation of the human interleukin-6 promoter Journal of General Virology 88(Pt 9): 2435-2440
Kanekiyo, M.; Itoh, N.; Kawasaki, A.; Tanaka, J.; Nakanishi, T.; Tanaka, K. 2001: Zinc-induced activation of the human cytomegalovirus major immediate-early promoter is mediated by metallothionein and nuclear factor-kappaB Toxicology and Applied Pharmacology 173(3): 146-153
Park, C.G.; Han, T.H.; Hwang, E.S.; Park, J.W.; Kook, Y.H.; Cha, C.Y. 1997: Role of human cytomegalovirus immediate-early2 protein in transcriptional activation of the c-jun promoter Abstracts of the General Meeting of the American Society for Microbiology 97: 305
Malone, C.L.; Vesole, D.H.; Stinski, M.F. 1990: Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins Journal of Virology 64(4): 1498-1506
Martínez, F.P.; Cosme, R.S.C.; Tang, Q. 2010: Murine cytomegalovirus major immediate-early protein 3 interacts with cellular and viral proteins in viral DNA replication compartments and is important for early gene activation Journal of General Virology 91(Part 11): 2664-2676
DeMeritt, I.B.; Podduturi, J.P.; Tilley, A.M.; Nogalski, M.T.; Yurochko, A.D. 2006: Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression Virology 346(1): 15-31
Arinze, I.J.; Kawai, Y. 2005: Transcriptional activation of the human Galphai2 gene promoter through nuclear factor-kappaB and antioxidant response elements Journal of Biological Chemistry 280(11): 9786-9795
Majano, P.; Lara-Pezzi, E.; López-Cabrera, M.; Apolinario, A.; Moreno-Otero, R.; García-Monzón, C. 2001: Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation Hepatology 34(6): 1218-1224
Isomura, H.; Stinski, M.F.; Kudoh, A.; Nakayama, S.; Iwahori, S.; Sato, Y.; Tsurumi, T. 2007: The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis Journal of Virology 81(12): 6197-6206
Kerry, J.A.; Priddy, M.A.; Stenberg, R.M. 1994: Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products Journal of Virology 68(7): 4167-4176
Poole, E.; Sinclair, J. 2022: Latency-associated upregulation of SERBP1 is important for the recruitment of transcriptional repressors to the viral major immediate early promoter of human cytomegalovirus during latent carriage Frontiers in Microbiology 13: 999290
Depto, A.S.; Stenberg, R.M. 1989: Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products Journal of Virology 63(3): 1232-1238
Poole, E.; Atkins, E.; Nakayama, T.; Yoshie, O.; Groves, I.; Alcami, A.; Sinclair, J. 2008: NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86 Journal of Virology 82(9): 4250-4256